Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 60.31% is in line with its 5-year average of 58.36%, near the high end of its 5-year range (31.63%–66.43%).
0.53% below its 12-month average of 60.63%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 66.43%.
GROSS MARGIN
60.31%
GROSS MARGIN AVG TTM
60.63%
GROSS MARGIN AVG 3Y
60.87%
GROSS MARGIN AVG 5Y
58.36%
GROSS MARGIN AVG 10Y
59.03%
GROSS MARGIN AVG 15Y
58.40%
GROSS MARGIN AVG 20Y
51.88%
CURRENT VS TTM AVG
-0.53%
CURRENT VS 3Y AVG
-0.92%
CURRENT VS 5Y AVG
+3.33%
CURRENT VS 10Y AVG
+2.17%
CURRENT VS 15Y AVG
+3.26%
CURRENT VS 20Y AVG
+16.24%
SECTOR MEDIAN · HEALTHCARE
40.92%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
+47.37%
vs the sector median at left
Market Cap
$36.28M
Gross Margin
39.56%
TTM Avg
49.73%
3Y Avg
-33.76%
5Y Avg
-21.28%
Market Cap
$36.23M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
Market Cap
$35.69M
Gross Margin
41.73%
TTM Avg
31.44%
3Y Avg
27.18%
5Y Avg
29.99%
Market Cap
$35.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$37.75M
Gross Margin
0.00%
TTM Avg
-93.03%
3Y Avg
-21.51%
5Y Avg
10.85%
Market Cap
$34.42M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nephros, Inc. (NEPH) | $36.37M | 60.31% | 60.63% | 60.87% | 58.36% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | 39.56% | 49.73% | -33.76% | -21.28% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | 0.00% | 0.00% | 0.00% | 22.09% |
| DocGo Inc. (DCGO)vs › | $35.81M | 30.12% | 32.64% | 32.93% | 33.24% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | 41.73% | 31.44% | 27.18% | 29.99% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.94M | 0.00% | 0.00% | 0.00% | 15.78% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Incannex Healthcare Limited (IXHL)vs › | $37.75M | 0.00% | -93.03% | -21.51% | 10.85% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 0.00% | 0.00% | 0.00% | 10.20% |
| Elutia Inc (ELUT)vs › | $34.48M | 57.82% | 48.80% | 47.77% | 46.56% |
Gross Margin
60.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 66.43% |
| 2026-03-31 | 56.87% |
| 2025-12-31 | 55.42% |
| 2025-09-30 | 61.19% |
| 2025-06-30 | 63.25% |
| 2025-03-31 | 64.67% |
| 2024-12-31 | 63.95% |
| 2024-09-30 | 61.09% |
| 2024-06-30 | 58.79% |
| 2024-03-31 | 62.10% |
| 2023-12-31 | 62.11% |
| 2023-09-30 | 58.63% |
| 2023-06-30 | 56.81% |
| 2023-03-31 | 57.10% |
| 2022-12-31 | 58.99% |
| 2022-09-30 | 31.63% |
| 2022-06-30 | 48.95% |
| 2022-03-31 | 48.77% |
| 2021-12-31 | 53.13% |
| 2021-09-30 | 52.75% |
| 2021-06-30 | 56.27% |
| 2021-03-31 | 58.00% |
| 2020-12-31 | 55.78% |
| 2020-09-30 | 57.76% |
| 2020-06-30 | 56.75% |
| 2020-03-31 | 58.96% |
| 2019-12-31 | 60.11% |
| 2019-09-30 | 58.77% |
| 2019-06-30 | 59.20% |
| 2019-03-31 | 56.42% |
| 2018-12-31 | 59.18% |
| 2018-09-30 | 55.22% |
| 2018-06-30 | 60.76% |
| 2018-03-31 | 47.41% |
| 2017-12-31 | 60.62% |
| 2017-09-30 | 58.08% |
| 2017-06-30 | 60.19% |
| 2017-03-31 | 61.99% |
| 2016-12-31 | 51.81% |
| 2016-09-30 | 66.53% |
| 2016-06-30 | 58.35% |
| 2016-03-31 | 50.00% |
| 2015-12-31 | 49.51% |
| 2015-09-30 | 51.88% |
| 2015-06-30 | 63.14% |
| 2015-03-31 | 51.84% |
| 2014-12-31 | 63.16% |
| 2014-09-30 | 64.36% |
| 2014-06-30 | 67.80% |
| 2014-03-31 | 77.59% |
| 2013-12-31 | -27.43% |
| 2013-09-30 | 54.78% |
| 2013-06-30 | 60.70% |
| 2013-03-31 | 62.38% |
| 2012-12-31 | 21.47% |
| 2012-09-30 | 68.38% |
| 2012-06-30 | 88.41% |
| 2012-03-31 | 58.35% |
| 2011-12-31 | 32.11% |
| 2011-09-30 | 75.92% |
| 2011-06-30 | 31.87% |
| 2011-03-31 | 29.22% |
| 2010-12-31 | 28.43% |
| 2010-09-30 | 48.71% |
| 2010-06-30 | 34.86% |
| 2010-03-31 | 39.33% |
| 2009-12-31 | 37.75% |
| 2009-09-30 | 34.88% |
| 2009-06-30 | 36.24% |
| 2009-03-31 | 28.37% |
| 2008-12-31 | 6.82% |
| 2008-09-30 | 35.37% |
| 2008-06-30 | 35.97% |
| 2008-03-31 | 38.50% |
| 2007-12-31 | 33.11% |
| 2007-09-30 | -16.96% |
| 2007-06-30 | 29.60% |
| 2007-03-31 | 30.74% |
| 2006-12-31 | 12.68% |
| 2006-09-30 | -23.16% |
| 2006-06-30 | -52.79% |
| 2006-03-31 | 16.07% |
| 2005-12-31 | 129.85% |
| 2005-09-30 | 32.68% |
| 2005-06-30 | 49.79% |
| 2005-03-31 | 92.88% |
| 2004-12-31 | -15.69% |
| 2004-09-30 | 16.88% |
| 2004-06-30 | 0.00% |